InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by HALKUFF DAWN, Director. Director active across 1 company, notably Xeris Biopharma Holdings, Inc.. Aggregated, 6 reports have been recorded. Split: 1 buy · 1 sell. Total volume traded: €274k. History available since 8 June 2022. The latest transaction was filed on 12 August 2025 (Cession). Regulator: SEC (Form 4). All data is free.
6 of 6 declarations
Dawn Halkuff is a Director at Xeris Biopharma Holdings, Inc. She plays a vital role in corporate governance and strategic decision-making. As a board member, she helps guide Xeris Biopharma's growth initiatives. Her experience in the biopharmaceutical sector is an asset for the company.